Squeeze Report — July 6, 2026
Biotech dominates today's book with a cluster of binary PDUFA dates and Q2 earnings acting as potential flashpoints for heavily shorted, cash-burning names. The standout setups pit extreme borrow stress and imminent catalysts against massive dilution overhangs, making the next few weeks a high-stakes pressure test for trapped shorts.
Today's top short-squeeze candidates
- #1ORICOric Pharmaceuticals, Inc. Com85
A 43% short interest and 48% surge are fighting an active $200M ATM and an SEC enforcement action against an officer.
SI 43%DTC 10.3$11.64+48% 20dHealthcare - #2AVTXAvalo Therapeutics, Inc. Commo82
A stale 68% short-interest print collides with a lock-up expiry today, creating immediate selling pressure against the squeeze thesis.
SI 68%DTC 5.5$18.84+37% 20dHealthcare - #3GPGIGPGI, Inc.81
Insiders bought 19 times into a 44% rally, while 18 days to cover and cheap options set the stage for a gamma event.
SI 36%DTC 18.1$16.75+44% 20dIndustrials - #4TRIPTripAdvisor, Inc. Common Stock81
The $700M TheFork sale adds cash, but cheap borrow and structural AI headwinds in Hotels blunt the 30% short interest threat.
SI 30%DTC 6.8$14.29+20% 20dCommunication Services - #5CRVSCorvus Pharmaceuticals, Inc. C81
A 25% short interest and 14-day cover period are undermined by a $200M ATM and negligible borrow costs.
SI 25%DTC 14.4$15.23+31% 20dHealthcare - #6CADLCandel Therapeutics, Inc. Comm81
A 28.7% short interest faces a Q4 BLA submission for prostate cancer, backed by fresh Lancet data and a $26 analyst target.
SI 29%DTC 7.6$9.83+12% 20dHealthcare - #7CERTCertara, Inc. Common Stock80
27% of float sold short · 7.2 days to cover · +24% over 20 days
SI 27%DTC 7.3$6.97+24% 20dHealthcare - #8VERAVera Therapeutics, Inc. Class79
Shorts are trapped into Monday's PDUFA for atacicept with 10.4 days to cover and a 32% pre-decision rally.
SI 20%DTC 10.4$41.20+32% 20dHealthcare - #9DRVNDriven Brands Holdings Inc. Co78
16% of float sold short · 8.5 days to cover · +13% over 20 days
SI 16%DTC 8.5$14.47+13% 20dConsumer Cyclical - #10SGMTSagimet Biosciences Inc. Serie78
19% of float sold short · 9.0 days to cover · +11% over 20 days
SI 19%DTC 9.0$7.61+11% 20dHealthcare - #11LIONLionsgate Studios Corp.77
44% of float sold short · 5.7 days to cover · +10% over 20 days
SI 44%DTC 5.7$14.66+10% 20dTechnology - #12IMVTImmunovant, Inc. Common Stock77
Despite a 25% short interest, a 0.25% borrow fee and insider selling suggest shorts are not yet under acute pressure.
SI 25%DTC 14.1$38.79+25% 20dHealthcare - #13CELCCelcuity Inc. Common Stock77
A 40% short interest stares down a July 17 PDUFA for gedatolisib, with a 21% rally already squeezing the borrow.
SI 40%DTC 4.3$107.95+21% 20dHealthcare - #14REPLReplimune Group, Inc. Common S77
30% of float sold short · 4.8 days to cover · +16% over 20 days
SI 30%DTC 4.8$11.58+16% 20dHealthcare - #15PTCTPTC Therapeutics, Inc. Common77
16% of float sold short · 7.8 days to cover · +21% over 20 days
SI 16%DTC 7.8$83.31+21% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →